Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Coronavirus disease 2019 (COVID-19) first emerged in late 2019 in China. At the time of writing, its causative agent SARS-CoV-2 has spread worldwide infecting over 9 million individuals and causing more than 460,000 deaths. In the absence of vaccines, we are facing the dramatic challenge of controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Aricò, Eleonora, Bracci, Laura, Castiello, Luciano, Gessani, Sandra, Belardelli, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334951/
https://www.ncbi.nlm.nih.gov/pubmed/32665127
http://dx.doi.org/10.1016/j.cytogfr.2020.07.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334951/
https://www.ncbi.nlm.nih.gov/pubmed/32665127
http://dx.doi.org/10.1016/j.cytogfr.2020.07.010

Ejemplares similares